 Featured News October 23, 2008
Med BioGene Broadens Commercialization Team to Oversee Launch Preparations for LungExpress Dx™ Gene Expression Test
June 16, 2008
Med BioGene Expands Lymphoma Collaboration; Becomes Founding Corporate Collaborator of Translational Working Group in Hematologic Malignancies
May 29, 2008
Med BioGene Appoints Diagnostics Industry Veteran Dr. Heiner Dreismann to Board of Directors
April 23, 2008
Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test
|
News Archives 2007 February 01, 2007
Med BioGene Announces Further Promising Results on the Diagnostic Value of its Lymphoma Genetic Biomarkers
February 08, 2007
Med BioGene Receives $307,000 Contribution from National Research Council Canada to Develop Genetic Biomarkers for Cardiovascular Disease
February 15, 2007
Med BioGene Enters Development Phase For Genetic Screening Test For Colorectal Cancer
February 15, 2007
Med BioGene Engages The Howard Group Inc. to Provide Investor and Financial Relations Services
February 27, 2007
Med BioGene Appoints Dr. Richard C. Cook to its Scientific Advisory Board
March 19, 2007
Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia for use in Diagnosis, Prognosis and Drug Development
June 18, 2007
Med BioGene Inc. to Close Second and Final Tranche of Private Placement on June 29, 2007
July 30, 2007
Med BioGene Inc. Dr. Nathan Yoganathan, President and Chief Scientific Officer, Transitions to Senior Advisory Role; Dr. Bradley McLean Appointed Chief Scientific Officer
September 10, 2007
Med BioGene Inc. Engages Peterson Capital to Provide Investor and Financial Relations Services
September 24, 2007
Med BioGene Appoints Dr. Melanie M. Mahtani as Executive Advisor, Commercial Development
|
E-MAIL ALERTS
Subscribe to our e-mail news alerts
Quick Facts
Download our facts sheet
|
Home 
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer